NexBio Starts Flu Drug Trial in Mexico and US

7 January 2010 (Last Updated January 7th, 2010 18:30)

NexBio has started trials in Mexico and the US of DAS181 (Fludase) for the treatment of laboratory-confirmed influenza. DAS181 is an investigational drug candidate that blocks the entry of the influenza virus into cells of the respiratory tract. The trial will assess the drug'

NexBio has started trials in Mexico and the US of DAS181 (Fludase) for the treatment of laboratory-confirmed influenza.

DAS181 is an investigational drug candidate that blocks the entry of the influenza virus into cells of the respiratory tract.

The trial will assess the drug's impact on the viral load as well as its safety and tolerability.